ZSHK, a pre-clinical Contract Research Organization (“Preclinical CRO”), raised funds from AZ-CICC and its existing investor Jishi Capital to enhance international deployment and key resources construction ZSHK Laboratories Limited (“ZSHK LAB”) (Chinese: 滬港中科), a pre-clinical CRO, an
Read more: https://equalocean.com/news/2022120119256